Stem-cell, precursor cell, or target cell-based treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/12 (2006.01)

Patent

CA 2521217

Methods for the treatment of acute renal failure, multi-organ failure, early dysfunction of kidney transplant, chronic renal failure, organ dysfunction, and wound healing are provided. The methods include delivering a therapeutic amount of hematopoietic stem cells, non-hematopoietic, mesenchymal stem cells, hemangioblasts, and pre-differentiated cells to a patient in need thereof.

L'invention concerne des procédés destinés au traitement de l'insuffisance rénale aiguë, de la défaillance multiviscérale, du dysfonctionnement précoce de la greffe de rein, de l'insuffisance rénale chronique, de la défaillance viscérale et de la cicatrisation. Les procédés de l'invention consistent à administrer une dose thérapeutique de cellules souches hématopoïétiques, de cellules souches non hématopoïétiques, de cellules souches mésenchymateuses, d'hémangioblastes, et de cellules pré-différenciées à un patient nécessitant un tel traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Stem-cell, precursor cell, or target cell-based treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stem-cell, precursor cell, or target cell-based treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem-cell, precursor cell, or target cell-based treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1932655

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.